Literature DB >> 12496146

Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium.

Hidenori Matsui1, Masato Suzuki, Yasunori Isshiki, Chie Kodama, Masahiro Eguchi, Yuji Kikuchi, Kenji Motokawa, Akiko Takaya, Toshifumi Tomoyasu, Tomoko Yamamoto.   

Abstract

We evaluated the efficacy of mutants with a deletion of the stress response protease gene as candidates for live oral vaccine strains against Salmonella infection through infection studies with mice by using a Salmonella enterica serovar Typhimurium mutant with a disruption of the ClpXP or Lon protease. In vitro, the ClpXP protease regulates flagellum synthesis and the ClpXP-deficient mutant strain exhibits hyperflagellated bacterial cells (T. Tomoyasu et al., J. Bacteriol. 184:645-653, 2002). On the other hand, the Lon protease negatively regulates the efficacy of invading epithelial cells and the expression of invasion genes (A. Takaya et al., J. Bacteriol. 184:224-232, 2002). When 5-week-old BALB/c mice were orally administered 5 x 10(8) CFU of the ClpXP- or Lon-deficient strain, bacteria were detected with 10(3) to 10(4) CFU in the spleen, mesenteric lymph nodes, Peyer's patches, and cecum 1 week after inoculation and the bacteria then decreased gradually in each tissue. Significant increases of lipopolysaccharide-specific immunoglobulin G (IgG) and secretory IgA were detected at week 4 and maintained until at least week 12 after inoculation in serum and bile, respectively. Immunization with the ClpXP- or Lon-deficient strain protected mice against oral challenge with the serovar Typhimurium virulent strain. Both the challenged virulent and immunized avirulent salmonellae were completely cleared from the spleen, mesenteric lymph nodes, Peyer's patches, and even cecum 5 days after the challenge. These data indicate that Salmonella with a disruption of the ATP-dependent protease ClpXP or Lon can be useful in developing a live vaccine strain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496146      PMCID: PMC143154          DOI: 10.1128/IAI.71.1.30-39.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection.

Authors:  H W Mittrücker; B Raupach; A Köhler; S H Kaufmann
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  Typhoid fever--important issues still remain.

Authors:  T Pang; M M Levine; B Ivanoff; J Wain; B B Finlay
Journal:  Trends Microbiol       Date:  1998-04       Impact factor: 17.079

Review 3.  Immune response to infection with Salmonella typhimurium in mice.

Authors:  H W Mittrücker; S H Kaufmann
Journal:  J Leukoc Biol       Date:  2000-04       Impact factor: 4.962

4.  Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium.

Authors:  S J McSorley; B T Cookson; M K Jenkins
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  Immunosuppression and nitric oxide production induced by parenteral live Salmonella vaccines do not correlate with protective capacity: a phoP::Tn10 mutant does not suppress but does protect.

Authors:  T K Eisenstein; J J Meissler; S I Miller; B A Stocker
Journal:  Vaccine       Date:  1998-01       Impact factor: 3.641

6.  Use of confocal microscopy to detect Salmonella typhimurium within host cells associated with Spv-mediated intracellular proliferation.

Authors:  H Matsui; M Eguchi; Y Kikuchi
Journal:  Microb Pathog       Date:  2000-07       Impact factor: 3.738

7.  Analysis of host cells associated with the Spv-mediated increased intracellular growth rate of Salmonella typhimurium in mice.

Authors:  P A Gulig; T J Doyle; J A Hughes; H Matsui
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

8.  Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha.

Authors:  T Yamamoto; H Sashinami; A Takaya; T Tomoyasu; H Matsui; Y Kikuchi; T Hanawa; S Kamiya; A Nakane
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

9.  Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium.

Authors:  S J McSorley; M K Jenkins
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

10.  Mutation of the htrB gene in a virulent Salmonella typhimurium strain by intergeneric transduction: strain construction and phenotypic characterization.

Authors:  M G Sunshine; B W Gibson; J J Engstrom; W A Nichols; B D Jones; M A Apicella
Journal:  J Bacteriol       Date:  1997-09       Impact factor: 3.490

View more
  20 in total

1.  Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains.

Authors:  Chie Kodama; Hidenori Matsui
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

2.  Identification of the proteasome inhibitor MG262 as a potent ATP-dependent inhibitor of the Salmonella enterica serovar Typhimurium Lon protease.

Authors:  Hilary Frase; Jason Hudak; Irene Lee
Journal:  Biochemistry       Date:  2006-07-11       Impact factor: 3.162

Review 3.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

Review 4.  Bacterial proteases, untapped antimicrobial drug targets.

Authors:  Elizabeth Culp; Gerard D Wright
Journal:  J Antibiot (Tokyo)       Date:  2016-11-30       Impact factor: 2.649

5.  Azithromycin inhibits the formation of flagellar filaments without suppressing flagellin synthesis in Salmonella enterica serovar typhimurium.

Authors:  Hidenori Matsui; Masahiro Eguchi; Katsufumi Ohsumi; Akio Nakamura; Yasunori Isshiki; Kachiko Sekiya; Yuji Kikuchi; Tohru Nagamitsu; Rokuro Masuma; Toshiaki Sunazuka; Satoshi Omura
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.

Authors:  Sharon M Tennant; Jin-Yuan Wang; James E Galen; Raphael Simon; Marcela F Pasetti; Orit Gat; Myron M Levine
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

7.  Enterobacterial common antigen mutants of Salmonella enterica serovar Typhimurium establish a persistent infection and provide protection against subsequent lethal challenge.

Authors:  Jeremy J Gilbreath; Jennifer Colvocoresses Dodds; Paul D Rick; Mark J Soloski; D Scott Merrell; Eleanor S Metcalf
Journal:  Infect Immun       Date:  2011-10-24       Impact factor: 3.441

8.  Flagella facilitate escape of Salmonella from oncotic macrophages.

Authors:  Gen-ichiro Sano; Yasunari Takada; Shinichi Goto; Kenta Maruyama; Yutaka Shindo; Kotaro Oka; Hidenori Matsui; Koichi Matsuo
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

9.  Physiology, pathogenicity and immunogenicity of lon and/or cpxR deleted mutants of Salmonella Gallinarum as vaccine candidates for fowl typhoid.

Authors:  Kiku Matsuda; Atul A Chaudhari; Sam Woong Kim; Kyeong Min Lee; John Hwa Lee
Journal:  Vet Res       Date:  2010-05-21       Impact factor: 3.683

Review 10.  Functional mechanics of the ATP-dependent Lon protease- lessons from endogenous protein and synthetic peptide substrates.

Authors:  Irene Lee; Carolyn K Suzuki
Journal:  Biochim Biophys Acta       Date:  2008-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.